This article is a correction to:
Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
Yunxiong Wei
Yaqing Cao
Rui Sun1
Wenyi Lu
Mingfeng Zhao- 1The First Central Clinical College of Tianjin Medical University, Tianjin, China
- 2Nankai University School of Medicine, Tianjin, China
- 3Department of Hematology, Tianjin First Central Hospital, Tianjin, China
A Corrigendum on
Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
By Wei Y, Cao Y, Sun R, Cheng L, Xiong X, Jin X, He X, Lu W and Zhao M (2020). Front. Oncol. 10:584974. doi: 10.3389/fonc.2020.584974
In the published article, there was an error regarding the affiliation(s) for Mingfeng Zhao. Instead of “Mingfeng Zhao 1,3”, it should be “Mingfeng Zhao 3”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: B cell lymphoma 2, AML—acute myeloid leukemia, venetoclax (ABT-199), intrinsic apoptosis, Bcl-2 protein
Citation: Wei Y, Cao Y, Sun R, Cheng L, Xiong X, Jin X, He X, Lu W and Zhao M (2020) Corrigendum: Targeting Bcl-2 Proteins in Acute Myeloid Leukemia. Front. Oncol. 10:632775. doi: 10.3389/fonc.2020.632775
Received: 24 November 2020; Accepted: 25 November 2020;
Published: 17 December 2020.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2020 Wei, Cao, Sun, Cheng, Xiong, Jin, He, Lu and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mingfeng Zhao, mingfengzhao@sina.com